Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Cash & Current Investments (2016 - 2025)

InspireMD (NSPR) has 16 years of Cash & Current Investments data on record, last reported at $63.4 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 56.93% year-over-year to $63.4 million; the TTM value through Sep 2025 reached $63.4 million, up 56.93%, while the annual FY2024 figure was $34.6 million, 11.24% down from the prior year.
  • Cash & Current Investments reached $63.4 million in Q3 2025 per NSPR's latest filing, up from $19.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $63.4 million in Q3 2025 and bottomed at $12.9 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $34.3 million, with a median of $34.6 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 1301.91% in 2021, then tumbled 58.92% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $34.0 million in 2021, then plummeted by 47.7% to $17.8 million in 2022, then soared by 119.19% to $39.0 million in 2023, then fell by 11.24% to $34.6 million in 2024, then skyrocketed by 83.05% to $63.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $63.4 million in Q3 2025, $19.4 million in Q2 2025, and $26.1 million in Q1 2025.